Drug recall · September 25, 2024
AcetaZOLAMIDE Tablets recall
Why: Discoloration
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
AcetaZOLAMIDE Tablets, USP, 125 mg, 100 count bottled, Rx Only, Distributed by: Advagen Pharma Limited, Plainsboro, NJ, Manufactured by Rubicon Research Private Limited, Thane, India NDC 72888-047-01
- Lots / codes
Lot # 30575HF1, exp. date, Nov 2026 NDC# 72888-047-01
- Quantity
- 3,984 bottles
- Company
- Rubicon Research Private Limited, Ambarnath
- Distribution
- Nationwide in the US
- Initiated
- August 24, 2024 · Voluntary: Firm initiated
- Classified
- September 13, 2024
- Reported
- September 25, 2024
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Acetazolamide
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.